Study of Dexamethasone as an Adjuvant to Levobupivacaine for analgesic efficacy in Infraclavicular Brachial Plexus Block in patients undergoing Upper Limb Surgery

Study of Dexamethasone as an Adjuvant to Levobupivacaine for Analgesic efficacy in Infraclavicular Brachial Plexus Block in patients undergoing Upper Limb Surgery - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079126

Enrollment

Registered

2025-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: X92-Y09- Assault Health Condition 3: M96-M96- Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Perineural Levobupivacaine with Dexamethasone: To evaluate the duration of analgesia with perineural Levobupivacaine with Dexamethasone in Infraclavicular Brachial Plexus Block for uppe

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with American Society of Anaesthesiologists grade I and II 2. Patients between age of 18-60 years, giving valid informed and written consent

Exclusion criteria

Exclusion criteria: 1. Patients with inability to comprehense pain 2. Patients who have allergy to study drugs 3. Patients with local site infections 4. Patients having coagulation abnormalities 5. Patients who are on prolonged analgesics

Design outcomes

Primary

Measure	Time frame
Duration of sensory and motor BlockTimepoint: Every 1 hr till it resolves	—

Secondary

Measure	Time frame
Quality of analgesiaTimepoint: Every 1 hr till it resolves	—

Countries

India

Contacts

Public ContactDr Sarvjeet Kaur

GGSMCH, Faridkot

drsarvjeetk@gmail.com9915680508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026